On Tuesday, HealthEquity reached an important technical milestone, seeing its Relative Strength (RS) Rating jump into the 80-plus percentile with an improvement to 80, up from 64 the day before.
Risk Management In The Stock Market: How Much Money To Invest Now
This proprietary rating tracks technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the trailing 52 weeks matches up against the rest of the market.
Over 100 years of market history reveals that the best-performing stocks typically have an RS Rating of over 80 in the early stages of their moves.
HealthEquity is building a cup without handle with a 115.59 entry. See if the stock can clear the breakout price in volume at least 40% higher than normal.
The company posted 10% EPS growth last quarter. Revenue gains came in at 19%. The next quarterly numbers are expected on or around Jun. 9.
The company earns the No. 3 rank among its peers in the Commercial Services-Outsourcing industry group. Red Violet is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
